Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Acorda Posts Profit, Outlook
Yahoo/Zacks
Saturday, February 19, 2011 - 11:32am
tags:
Acorda Therapeutics
Dendreon Adds Ammo to Provenge Defense
Minyanville
Saturday, February 19, 2011 - 11:13am
tags:
Dendreon, Provenge
Good News for Bristol-Myers
Yahoo/Zacks
Saturday, February 19, 2011 - 11:12am
tags:
Bristol-Myers Squibb
Genzyme expects writedown for layoffs, up to $23M
Yahoo/AP
Saturday, February 19, 2011 - 11:11am
tags:
Genzyme
Merck Vioxx Accord Spawns Pay-Day Scrap Among Lawyers
Bloomberg
Saturday, February 19, 2011 - 11:10am
tags:
Merck, Vioxx, lawsuits
Top Biotech Takeout Targets in 2011
Minyanville
Friday, February 18, 2011 - 3:32pm
tags:
M&A, biotech, Biogen Idec, Human Genome, Seattle Genetics, GSK, Dendreon, Actelion, Biomarin, Exelixis, Vertex Pharmaceuticals, Celgene, Alexion, Shire, InterMune, Lexicon Pharmaceuticals, Savient, Merck KGaA
Genzyme advances 2nd Gaucher drug
Bizjournals.com
Friday, February 18, 2011 - 3:22pm
tags:
Gaucher disease, Genzyme
Watson’s Bisaro Tells CNBC Generic Lipitor to Be ‘Huge Product’
Bloomberg
Friday, February 18, 2011 - 3:20pm
tags:
Watson Pharmaceuticals, Paul Bisaro, generics, Lipitor, Pfizer
Impax Laboratories gets FDA approval for generic version of antibiotic Adoxa
Yahoo/AP
Friday, February 18, 2011 - 3:19pm
tags:
Impax, FDA, generics, antibiotics, Adoxa
Obama asks judge for clarity on health care ruling
Bizjournals.com
Friday, February 18, 2011 - 3:18pm
tags:
Obama, healthcare reform
PDL Settles MedImmune Dispute
Yahoo/Zacks.com
Friday, February 18, 2011 - 3:17pm
tags:
PDL Biopharma, MedImmune, AstraZeneca, RSV, Synagis, Abbott Laboratories
Investors scour biotechs in search of the next big payoff
Fierce Biotech
Friday, February 18, 2011 - 9:40am
tags:
investors, biotech, Dendreon, Human Genome Sciences, Biomarin, Alexion
How Many New Drugs Did FDA Approve Last Year?
Pharmalot
Friday, February 18, 2011 - 9:37am
tags:
FDA, drug approvals
Biotech Mailbag: BIO CEO Wrap
TheStreet.com
Friday, February 18, 2011 - 9:36am
tags:
BIO CEO Conference, Rexahn, Nymox, MannKind, Teva Pharmaceuticals, Somaxon, Medivation, Cell Therapeutics, YM BioSciences
Good News for Dendreon's Provenge
Seeking Alpha
Friday, February 18, 2011 - 9:33am
tags:
Provenge, prostate cancer, Dendreon, vaccines
What Sanofi-Genzyme Means for the Rest of Biotech
Motley Fool
Friday, February 18, 2011 - 9:32am
tags:
biotech, Sanofi, Genzyme, M&A
BioMarin Pharma reports 4Q loss on costs
Yahoo/AP
Friday, February 18, 2011 - 9:31am
tags:
earnings, Biomarin
Cramer's Mad Money - Big Pharma Is One Big Graveyard for Stocks
Seeking Alpha
Friday, February 18, 2011 - 9:24am
tags:
Allergan, Bristol-Myers Squibb, Express Scripts, GSK, Eli Lilly, Merck, Pfizer
Pfizer: Little Downside Risk, But Not That Much Upside
Seeking Alpha
Friday, February 18, 2011 - 9:19am
tags:
Pfizer
[video] Johnson & Johnson CEO on Road Ahead
CNBC
Friday, February 18, 2011 - 9:18am
tags:
JNJ, Pharma CEOs, William Weldon

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.